News
-
-
PRESS RELEASE
Amoéba: a first half of 2025 marked by numerous decisive achievements ahead of the commercial launch of its biocontrol solution in 2026
Amoéba achieved crucial milestones for the commercialisation of AXPERA and the development of its cosmetics segment, strengthening its financial structure with a successful capital increase -
-
PRESS RELEASE
Amoéba accelerates the development of Axpera: Very convincing results observed by winegrowers; An approval schedule in line with the market launch in 2026.
Amoéba to present positive results of wine-growing trials with its innovative biological solution 'AXPERA' to agricultural press, amidst changing plant health regulations in France and Europe -
-
-
-
PRESS RELEASE
Amoéba announces the success of its capital increase of 14 M EUR to support its industrial and commercial deployment
Amoéba (FR0011051598 - ALMIB) successfully raises €14 million through a capital increase to support industrial and commercial expansion. Investors incl. Nice & Green show confidence. New shares to be admitted on Euronext Growth market of Euronext Paris -
-
PRESS RELEASE
Amoéba launches a capital increase open to all to support its industrial and commercial deployment
Amoéba, a greentech company, announces a capital increase of up to €14 million to support industrial and commercial growth in biocontrol and cosmetics. Key partners and subscription commitments outlined